Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...

ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...

Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...

Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...

The Osaka High Court on Thursday upheld a lower court ruling that sentenced a former doctor to two years and six months in ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter ...

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...

The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...

KALAMAZOO, Mich. — A charity hockey game is on the way to Western Michigan University's (WMU) Lawson Ice Arena this spring.

There’s no cure and the statistics are discouraging, but there’s a mobile app that’s creating hope for people living with ALS and their caregivers.